Thema: US0021202025
LIFE, US0021202025
stock-6682491_1920.jpg - Foto: THN
aTyr Pharma stock faces mixed Phase 3 readout in sarcoidosis
aTyr Pharma stock draws focus after peer-reviewed Phase 3 results for efzofitimod in pulmonary sarcoidosis. The study produced a mixed clinical readout.
ad-hoc-news.de, 30.10.26 20:11 Uhr
LIFE, US0021202025
aTyr Pharma implements one-for-forty split. aTyr Pharma ...
On October 19, ATYR2810 entered preclinical osteosarcoma research. aTyr Pharma stock costs EUR 0.10 on October 27, 2026.
ad-hoc-news.de, 27.10.26 19:14 Uhr
LIFE, US0021202025
aTyr Pharma has November 5 2026 results. aTyr Pharma stock ...
Q3 results are set for November 5, 2026, with USD 2.50 million expected. aTyr Pharma stock stood at EUR 0.07 in Frankfurt on October 23, 2026.
ad-hoc-news.de, 24.10.26 18:39 Uhr
LIFE, US0021202025
aTyr Pharma stock: EUR 0.16 puts aTyr Pharma stock 196.30 ...
Average target rises to USD 3.20 on October 22, 2026. aTyr Pharma stock costs EUR 0.16 on October 22, 2026, up 196.30 percent versus Frankfurt close.
ad-hoc-news.de, 22.10.26 19:51 Uhr
LIFE, US0021202025
aTyr Pharma stock gains 185.71 percent versus Frankfurt ...
Q2 net loss reached USD 10.31 million. aTyr Pharma stock costs EUR 0.16 on October 20, 2026, up 185.71 percent versus Frankfurt close.
ad-hoc-news.de, 20.10.26 19:28 Uhr
LIFE, US0021202025
aTyr Pharma stock fell 5.56 percent to USD 0.17 on October ...
Market value stood at USD 17.1 million on October 16, 2026. aTyr Pharma stock closed at USD 0.17, down 5.56 percent on Nasdaq.
ad-hoc-news.de, 17.10.26 20:15 Uhr
LIFE, US0021202025
aTyr Pharma stock heads into November 5 earnings at USD ...
Second-quarter earnings per share came to USD -0.11 on June 30, 2026. aTyr Pharma stock costs EUR 0.17 on October 15, 2026 at 8:42 p.m. CEST.
ad-hoc-news.de, 15.10.26 20:54 Uhr
LIFE, US0021202025
aTyr Pharma stock faces October 16 reverse split vote
aTyr Pharma stock faces an October 16 vote on a 1-for-10 to 1-for-50 reverse split. ATYR was last at USD 0.28 on October 6, 2026.
ad-hoc-news.de, 07.10.26 01:25 Uhr
Pharma, Secures
aTyr Pharma Secures Pivotal FDA Meeting for 2026
